Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
GLAD-AML - Glasdegib (Pf-04449913) With Two Standard Decitabine Regimens for Older Patients With Poor-risk Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04051996. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy
ClinicalTrials.gov study NCT03839446. IPD Sharing: NO. Countries: 1. Publications: 0.
Flotetuzumab for the Treatment of Pediatric Recurrent or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04158739. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00725283. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Flotetuzumab for Relapsed Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Following Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)
ClinicalTrials.gov study NCT04582864. IPD Sharing: YES. Countries: 1. Publications: 0.
Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00666588. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy
ClinicalTrials.gov study NCT01334086. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess AC220 Given in Combination With Induction and Consolidation Therapy in Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01390337. IPD Sharing: YES. Countries: 1. Publications: 0.
Venetoclax and Quizartinib in Treating Patients With FLT3-mutated Recurrent or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03735875. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Idarubicin, Cytarabine, and Vorinostat With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00656617. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03318016. IPD Sharing: NO. Countries: 1. Publications: 0.
Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05066165. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00513305. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03760666. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
ClinicalTrials.gov study NCT03793478. IPD Sharing: YES. Countries: 10. Publications: 0.
JNJ-40346527 in Treating Participants With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03557970. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dasatinib, Cytarabine, and Idarubicin in Treating Patients With High-Risk Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01876953. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00358644. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine and Lenalidomide for Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01016600. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous L
ClinicalTrials.gov study NCT01690520. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.